BioSpace News Archive

BRAIN AG and Mannheim University of Applied Sciences Jointly Develop 3D Skin Models for Health Care and Cosmetics

As the first milestone of the project, the research partners HS Mannheim and BRAIN have published a review article entitled “in Vitro Skin Three-Dimensional Models and Their Applications” in the Journal of Cellular Biotechnology.

December 12, 2017
·
5 min read
Galapagos: Transparency Notification - Dec. 12, 2017

Galapagos received a transparency notification from Fidelity Management & Research LLC.

December 12, 2017
·
1 min read
Pharm Country

Fibrocell Announces Closing of $10.5M Underwritten Public Offering

H.C. Wainwright & Co. acted as the sole book-running manager for the Offering.

December 12, 2017
·
4 min read
Investors Initiate Tender Offer to Take BioCanCell Private Ahead of Planned Fundraising Round

Shareholders have until Sunday, December 24th, 2017, at 3:00pm IST to vote their acceptance of the offer.

December 12, 2017
·
3 min read
Biotech Bay

Aduro Biotech to Host a Program Update Call

The webcast will be archived and available for replay for one month following the event.

December 12, 2017
·
3 min read
Deals

Jupiter Life Sciences Consulting Acquires Alta Bioscience Consulting

The acquisition supports Jupiter’s rapid geographic expansion and grows its practice areas and payer network in the pharma and biotech industry.

December 12, 2017
·
2 min read
Genetown

Acer Therapeutics Announces Proposed Underwritten Public Offering of Common Stock

Acer intends to grant the underwriters a 30-day option to purchase an additional 15% of the shares of common stock offered in the public offering.

December 12, 2017
·
4 min read
Drug Development

Agios’ New Data From Ivosidenib Phase I Dose-Escalation and Expansion Trial Demonstrate Durable Responses in Patients With IDH1m Relapsed or Refractory AML

The CR+CRh rate is the primary endpoint of the study.

December 12, 2017
·
11 min read
Business

Almirall and Athenex Announce Strategic Partnership for the Treatment of Actinic Keratosis

Athenex will grant to Almirall an exclusive license under the Athenex IP to research, develop and commercialize KX2-391 in the United States of America and European countries, including Russia.

December 12, 2017
·
9 min read
Ossur Hf: Transactions in Relation to Share Buyback Program - Dec. 12, 2017

The program will end no later than 31 July 2018.

December 12, 2017
·
2 min read